2017
DOI: 10.12659/msmbr.904103
|View full text |Cite
|
Sign up to set email alerts
|

High-Performance Liquid Chromatography (HPLC) Quantification of Liposome-Delivered Doxorubicin in Arthritic Joints of Collagen-Induced Arthritis Rats

Abstract: BackgroundNeoangiogenesis occurring in inflamed articular synovium in early rheumatoid arthritis (RA) is characterized by enhanced vascular permeability that allows nanoparticle agents, including liposomes, to deliver encapsulated drugs to arthritic joints and subsequently improve therapeutic efficacy and reduce adverse effects. However, the targeting distribution of liposomes in arthritic joints during RA has not been quantitatively demonstrated. We performed this study to evaluate the targeting distribution … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 23 publications
(33 reference statements)
0
3
0
Order By: Relevance
“…The matrix effects for doxorubicin, doxorubicinol, doxorubicinone, doxorubicinolone, 7-deoxydoxorubicinone, and daunorubicin (IS) were 112.9-119.7%, 94.8-109.6%, 105.1-117.9%, 99.0-111.0%, 98.3-108.3%, and 88.0%, respectively, with RSD ≤ 14.2% at low, medium, and high QC levels (Table 2), indicating the presence of a small matrix effect. Liquid−liquid extraction using chloroform:methanol (4:1, v/v) resulted in higher sensitivity and smaller matrix effects for doxorubicin and its four metabolites compared with the protein precipitation method using methanol, acetonitrile, or acetone [13][14][15]18,19,21,22,[25][26][27]31,32,34,35]. Our method yielded LLOQ levels of doxorubicin (0.5 ng/mL) and its major four metabolites (0.1-0.01 ng/mL) that were better than those reported using the least plasma volume of 10 µL.…”
Section: Methods Validationmentioning
confidence: 99%
See 1 more Smart Citation
“…The matrix effects for doxorubicin, doxorubicinol, doxorubicinone, doxorubicinolone, 7-deoxydoxorubicinone, and daunorubicin (IS) were 112.9-119.7%, 94.8-109.6%, 105.1-117.9%, 99.0-111.0%, 98.3-108.3%, and 88.0%, respectively, with RSD ≤ 14.2% at low, medium, and high QC levels (Table 2), indicating the presence of a small matrix effect. Liquid−liquid extraction using chloroform:methanol (4:1, v/v) resulted in higher sensitivity and smaller matrix effects for doxorubicin and its four metabolites compared with the protein precipitation method using methanol, acetonitrile, or acetone [13][14][15]18,19,21,22,[25][26][27]31,32,34,35]. Our method yielded LLOQ levels of doxorubicin (0.5 ng/mL) and its major four metabolites (0.1-0.01 ng/mL) that were better than those reported using the least plasma volume of 10 µL.…”
Section: Methods Validationmentioning
confidence: 99%
“…Doxorubicinol, a major alcohol metabolite of doxorubicin formed by carbonyl reductases 1 and 3, is implicated in off-target cardiotoxicity of doxorubicin-treated patients [3,[7][8][9][10]. High-performance liquid chromatography (HPLC) with fluorescence [11][12][13][14][15][16][17][18][19] or ultraviolet (UV) [20,21] detection, LC with mass spectrometry (LC-MS) [22,23] or tandem mass spectrometry (LC-MS/MS) [24][25][26][27][28][29][30][31][32][33][34][35][36], and capillary electrophoresis [37][38][39] methods have been used to analyze doxorubicin alone or with its metabolite doxorubicinol in various biological matrices, such as blood, serum, plasma, cells, and tissues. Protein precipitation with methanol, acetonitrile, or acetone [13][14][15]18,19,21,22,[25][26][27]31,…”
Section: Introductionmentioning
confidence: 99%
“…The ow rate was 0.30 mL min À1 , and the injection volume was 5 mL. The column and sample temperature were maintained at 40 C and 4 C, 47,48 respectively. An Thermo Q EXACTIVE mass spectrometer equipped with an electro-spray ionization (ESI) source was used for mass spectrometric detection.…”
Section: In Vivo Pharmacokineticsmentioning
confidence: 99%